LEADER 04414nam  2201057z- 450 
001 9910566473003321
005 20231214133047.0
035   $a(CKB)5680000000037650
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81103
035   $a(EXLCZ)995680000000037650
100   $a20202205d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aSupramolecular Systems for Gene and Drug Delivery
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (218 p.)
311   $a3-0365-3377-X 
311   $a3-0365-3378-8 
330   $aDear Colleagues,Supramolecular systems (calixarenes, cyclodextrins, polymers, peptides, etc.) have attracted special attention due to their excellent therapeutic properties for biomedical applications such as gene and drug delivery. Numerous biomaterials-based supramolecular systems have been developed in the last decade for enhancing of biocompatibility and pharmacological activity. In particular, supramolecular nanomaterials are considered a hot research topic, because nanomedicine has become an interesting tool for the treatment of genetic diseases or cancer. Nevertheless, novel systems and their properties are being continuously studied, contributing to the development of efficient delivery systems.This Special Issue provides and highlights current progress in the use of the supramolecular systems for boosting gene and drug delivery. Preparation, characterization, and use of these systems, as well as the latest developments in this research field, are especially welcome.Authors are encorauged to submit original research articles and reviews in this promising research field.
606   $aResearch & information: general$2bicssc
606   $aChemistry$2bicssc
610   $a?-cyclodextrin-based nanosponge
610   $aphenylethylamine
610   $a2-amino-4-(4-chlorophenyl)thiazole (AT)
610   $agold nanoparticles
610   $acarrier of therapeutic agents
610   $aferritin
610   $adrug delivery
610   $atumor targeting
610   $ahalf-life extension
610   $aPAMAM dendrimers
610   $afolic acid
610   $amRNA
610   $agene expression
610   $along acting injectables
610   $apoly(l-lactic acid)
610   $apoly(butylene adipate)
610   $ablock copolymers
610   $aaripiprazole
610   $amicroparticles
610   $asustained release
610   $acationic calix[4]arenes
610   $aliposomes
610   $anucleic acids
610   $atransfection efficiency
610   $adoxorubicin
610   $aencapsulation
610   $aadenine-uracil base pair
610   $acomplementary hydrogen bonded drug carrier system
610   $acontrolled drug delivery
610   $asupramolecular nanogels
610   $aselective cytotoxicity
610   $asupramolecular self-assembled ribbon-like structures (SRLS)
610   $aCongo red (CR)
610   $adoxorubicin (Dox)
610   $abovine serum albumin (BSA)
610   $aimmunoglobulin light chain ? (L?)
610   $aheat aggregated immunoglobulins (HAI)
610   $adynamic light scattering (DLS)
610   $aelution volume (Ve)
610   $amulti-walled carbon nanotube
610   $aphotothermal therapy
610   $aindocyanine green
610   $asynergistic strategy
610   $acancer treatment
610   $atargeted drug delivery
610   $apillararene
610   $ahost:guest
610   $asupramolecular
610   $ahydrophobic
610   $aITC
610   $aNMR
610   $amagnetoliposomes
610   $amicrofluidics
610   $aoral drug delivery
610   $amagnetite nanoparticles
615  7$aResearch & information: general
615  7$aChemistry
700   $aOstos$b Francisco Jose?$4edt$01328540
702   $aLebro?n$b Jose? Antonio$4edt
702   $aLo?pez-Cornejo$b Pilar$4edt
702   $aOstos$b Francisco Jose?$4oth
702   $aLebro?n$b Jose? Antonio$4oth
702   $aLo?pez-Cornejo$b Pilar$4oth
906   $aBOOK
912   $a9910566473003321
996   $aSupramolecular Systems for Gene and Drug Delivery$93038663
997   $aUNINA